★ Sector
Dietary Supplements & Wellness
December 2025 – April 2026
- Orgs
- 1
- Actions
- 3
- Topics
- 3
Companies whose primary business is the manufacture and sale of dietary supplements, herbal and botanical products, and other wellness consumables marketed outside the prescription-drug regulatory framework. The sector spans vitamins, nutraceuticals, and botanical tonics such as kratom and kava products, which are sold as supplements rather than approved drugs and face a lighter federal regulatory regime than pharmaceuticals.
Organizations
Actions
Actions involving organizations in this sector, players affiliated with them, or sector-wide benefits.
- Botanic Tonics donates $1M to Kennedy-aligned MAHA PAC$1MPrivate ActionApril 2026
- Mullin pushes to ease FDA kratom rules while invested in Botanic TonicsGovernment ActionBeneficiaryDecember 2025
The kratom and broader botanical-supplement industry benefits from federal officials easing regulatory scrutiny — removing enforcement-action links from the FDA's website and moving against competing synthetic 7-OH products — which lowers the risk of state and federal bans on kratom-leaf products.
- Trump's Justice Department drops kratom case against Botanic TonicsGovernment ActionDecember 2025